TL;DR 

People with “metabolically obese normal weight” (MONW) can have insulin resistance and cardiovascular risks despite normal BMI. A controlled study found that daily magnesium supplementation improved blood pressure, fasting glucose, and triglycerides in MONW adults with low magnesium levels.

Not everyone who looks lean is metabolically healthy. The term “metabolically obese normal weight” (MONW) describes people who have a normal BMI but still show metabolic changes commonly seen in obesity—such as excess visceral fat, insulin resistance, high triglycerides, elevated blood pressure, and greater cardiovascular risk.

These individuals may appear healthy on the outside, yet have underlying metabolic disturbances that increase long-term disease risk.

Magnesium Supplementation in MONW Individuals

A double-blind, placebo-controlled study published in the Archives of Medical Research followed 47 MONW adults who had low serum magnesium (below 1.8 mg/dL), indicating hypomagnesemia.  Participants were randomly assigned to receive either:

  • Magnesium chloride, 382 mg per day (30 mL of a 2.5% solution), or

  • A placebo

The intervention lasted four months.

Key Findings

Compared to the placebo group, the people receiving magnesium showed:

  • Greater reductions in blood pressure

  • Lower fasting blood glucose

  • Reduced triglycerides

The researchers concluded:

“Oral magnesium supplementation improves the metabolic profile and blood pressure of MONW individuals.”

These findings support the idea that even people with normal BMI may benefit from addressing magnesium deficiency as part of supporting metabolic health—under the guidance of doctors trained in natural healthcare.